Patent assignee · DK · COMPANY

NsGene A/S

19Patents
13Active
19Granted
45Portfolio score

Filing activity: Jul 2, 1999 → Aug 22, 2014 · 7 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6593133B1 Neurotrophic factors Human Necessities 20 Expired
US6734284B1 Neublastin neurotrophic factors Human Necessities 18 Expired
US7276580B2 Neurotrophic factors Human Necessities 12 Expired
US7655463B2 Methods of activating RET receptor tyrosine kinase using neurotrophic factors Human Necessities 11 Active
US7358228B2 Methods of treating pain using neurotrophic factors Human Necessities 11 Active
US7601518B2 Secretion of neublastin Chemistry; Metallurgy 10 Expired
US7303912B2 Cultures of GFAP nestin cells that differentiate to neurons Chemistry; Metallurgy 6 Expired
US8404642B2 Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain Human Necessities 6 Active
US7651853B2 Cultures of GFAP+ nestin+ cells that differentiate to neurons Chemistry; Metallurgy 4 Active
US6555674B2 JeT promoter Chemistry; Metallurgy 3 Expired
US9068015B2 Therapeutic use of a growth factor, METRNL Human Necessities 2 Active
US8741340B2 Cell lines and their use in encapsulated cell biodelivery Chemistry; Metallurgy 2 Active
US8217146B2 Neurotrophic factors and methods of use thereof Human Necessities 2 Active
US9121037B2 Cell lines and their use in encapsulated cell biodelivery Chemistry; Metallurgy 2 Active
US8815810B2 Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain Human Necessities 1 Active
US9474786B2 Treatment of allodynia Human Necessities 0 Active
US8088567B2 Human immortalised neural precursor cell line Chemistry; Metallurgy 0 Active
US9364427B2 Implantable therapy system for treating a living being with an active factor Human Necessities 0 Active
US9314502B2 Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.